# SB 336: Relating to health benefit plan coverage of treatments for pediatric neuroinflammatory disorder.

90th Legislature (90R) · Senate · Status: Filed

Record current as of: the Legislative Council last updated this bill's record 11/21/2026 2:00:09 AM; this site copied it 2026-11-22T04:18:46.160732Z.

How to read this page: **Official record** is copied unchanged from the Texas Legislative Council's bill files, the data behind Texas Legislature Online. **Computed by this site** is worked out by fixed rules from that record. **AI analysis (Luna)** is written by an AI model that read the bill text; it can be wrong, so check it against the bill text.

## Official record

Source: Texas Legislative Council bill files (ftp.legis.state.tx.us), copied unchanged.

- Filed: 2026-11-10
- Most recent action: 2026-11-10 · Senate: Filed
- Official subjects (Legislative Council index): Health--Children's Insurance; Health--Other Diseases & Medical Conditions; Insurance--Health & Accident; INSURANCE, COMMISSIONER OF; INSURANCE, TEXAS DEPARTMENT OF
- Companion bills: [HB 386](https://agent.billatlas.org/bills/HB386.md), identical, by Lalani

### Caption

Relating to health benefit plan coverage of treatments for pediatric neuroinflammatory disorder.

### Bill text

The official wording of each version, copied from the Texas Legislative Council's bill text files and converted to Markdown with the wording unchanged. Language the bill adds is marked <ins>like this</ins>; language it removes is in [<del>brackets</del>]. To check a copy, fetch the official file and compare its SHA-256 with the one listed; the copy's own SHA-256 confirms you received it unaltered.

- Introduced: https://billatlas.org/live/text/SB336/I.md
  - Official file: ftp://ftp.legis.state.tx.us/bills/90R/billtext/HTML/senate_bills/SB00300_SB00399/SB00336I.HTM, last modified 2026-11-12 21:04:19 UTC, SHA-256 acb04be11a00845df993f983388bfd004c45272a50cc65bfb83ce2c9c5ed370e
  - This copy: made 2026-11-13T08:27:58.309882Z, SHA-256 of the Markdown 0f5f02e788901af9d7cdbbdc3bd6a774a4c574854d72573a6bf7ca72b8e8a541

#### Text of the latest version (Introduced)

````markdown
# SB 336 - Introduced

By: Menéndez S.B. No. 336

A BILL TO BE ENTITLED

AN ACT

relating to health benefit plan coverage of treatments for pediatric neuroinflammatory disorder.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:

### SECTION 1.

Chapter 1367, Insurance Code, is amended by adding Subchapter H to read as follows: <ins>SUBCHAPTER H. PEDIATRIC NEUROINFLAMMATORY DISORDERS</ins>

<ins>Sec. 1367.351. DEFINITIONS. In this subchapter:</ins>

<ins>(1) "Off-label use" means the use of a prescription drug or therapy approved for use by the United States Food and Drug Administration in a manner other than the approved use.</ins>

<ins>(2) "Pediatric neuroinflammatory disorder" means an immune-mediated inflammatory condition affecting the central nervous system in an individual younger than 18 years of age, including but not limited to autoimmune encephalitis, post-infectious encephalitis, acute disseminated encephalomyelitis (ADEM), optic neuritis, transverse myelitis, neuromyelitis optica spectrum disorder (NMOSD), pediatric acute-onset neuropsychiatric syndrome (PANS), pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS), and other clinically recognized neuroimmune or neuroinflammatory disorders diagnosed by a physician using accepted clinical criteria, diagnostic testing, and clinical judgment.</ins>

<ins>Sec. 1367.352. APPLICABILITY OF SUBCHAPTER. (a) This subchapter applies only to a health benefit plan that provides benefits for medical, surgical, or prescription drug expenses incurred as a result of a health condition, accident, or sickness, including an individual, group, blanket, or franchise insurance policy or insurance agreement, a group hospital service contract, or an individual or group evidence of coverage or similar coverage document that is issued by:</ins>

<ins>(1) an insurance company;</ins>

<ins>(2) a group hospital service corporation operating under Chapter 842;</ins>

<ins>(3) a health maintenance organization operating under Chapter 843;</ins>

<ins>(4) an approved nonprofit health corporation that holds a certificate of authority under Chapter 844;</ins>

<ins>(5) a multiple employer welfare arrangement that holds a certificate of authority under Chapter 846;</ins>

<ins>(6) a stipulated premium company operating under Chapter 884;</ins>

<ins>(7) a fraternal benefit society operating under Chapter 885;</ins>

<ins>(8) a Lloyd's plan operating under Chapter 941; or</ins>

<ins>(9) an exchange operating under Chapter 942.</ins>

<ins>(b) Notwithstanding any other law, this subchapter applies to:</ins>

<ins>(1) a basic coverage plan under Chapter 1551;</ins>

<ins>(2) a basic plan under Chapter 1575; and</ins>

<ins>(3) a primary care coverage plan under Chapter 1579.</ins>

<ins>Sec. 1367.353. COVERAGE REQUIRED. (a) A health benefit plan must provide coverage for the treatment of pediatric neuroinflammatory disorder if:</ins>

<ins>(1) that condition was diagnosed by a physician with appropriate specialty training, including neurology, pediatric neurology, pediatric immunology, pediatric rheumatology, and an equivalent specialty, based on accepted clinical criteria, diagnostic testing, and the physician's clinical judgment;</ins>

<ins>(2) the treatment is prescribed by the enrollee's treating physician as medically necessary for an individual diagnosed with that condition; and</ins>

<ins>(3) the enrollee's treating physician documents, in the enrollee's medical record, the clinical rationale for the treatment and the basis for the diagnosis of that condition.</ins>

<ins>(b) The coverage required by this section must include coverage of:</ins>

<ins>(1) the following treatments:</ins>

<ins>(A) immunomodulating therapies, including:</ins>

<ins>(i) intravenous immunoglobulin therapy;</ins>

<ins>(ii) rituximab;</ins>

<ins>(iii) therapeutic plasma exchange;</ins>

<ins>(iv) cyclophosphamide;</ins>

<ins>(v) mycophenolate mofetil;</ins>

<ins>(vi) azathioprine; and</ins>

<ins>(vii) other disease-modifying therapies used to treat pediatric neuroinflammatory disorder under accepted clinical practices;</ins>

<ins>(B) antibiotics; and</ins>

<ins>(C) behavioral therapy;</ins>

<ins>(2) costs related to inpatient or outpatient administration of a treatment described by Subdivision (1), including infusion services; and</ins>

<ins>(3) any other costs associated with administering a treatment described by Subdivision (1), including clinical monitoring, laboratory testing, imaging, and other ancillary services.</ins>

(c) In determining whether a treatment is medically necessary under this section, a health benefit plan issuer shall give substantial deference to the clinical judgment of the enrollee's treating physician who has appropriate experience in diagnosing or treating pediatric neuroimmune or neuroinflammatory disorders, taking into consideration the enrollee's clinical presentation, diagnostic findings, treatment history, and response to previous treatment.

<ins>Sec. 1367.354. APPROVAL OF TREATMENT. A health benefit plan issuer may not deny or delay approval of a treatment for which coverage is required under Section 1367.353 on the sole basis that:</ins>

<ins>(1) the treatment is prescribed for an off-label use or is classified by the health benefit plan issuer as experimental or investigational, if the treatment is medically necessary and supported by peer-reviewed medical literature, recognized clinical practice guidelines, or other generally accepted medical evidence applicable to the enrollee's condition;</ins>

<ins>(2) the enrollee has previously received the same treatment for pediatric neuroinflammatory disorder or another diagnosis; or</ins>

<ins>(3) the enrollee's diagnosis is listed under a diagnostic code or label other than pediatric neuroinflammatory disorder.</ins>

<ins>Sec. 1367.355. LIMIT ON COST-SHARING REQUIREMENT. A health benefit plan issuer may not impose a cost-sharing requirement, including a copayment, coinsurance cost, or deductible for a treatment required to be covered under Section 1367.353 that is greater than the cost-sharing requirement applied to other covered health care services within the same benefit tier under the enrollee's health benefit plan.</ins>

<ins>Sec. 1367.356. PROHIBITION ON MULTIPLE PREAUTHORIZATIONS. For purposes of this section, a subsequent prescription, treatment order, infusion, or administration of the same treatment during the applicable 12-month period does not constitute a new treatment requiring additional preauthorization solely because the treatment is prescribed or administered in separate doses or courses, provided the treatment remains medically necessary for the covered condition under Section 1367.353.</ins>

<ins>Sec. 1367.357. REPORTING. (a) The department shall:</ins>

<ins>(1) collect data on any denial or appeal of a denial of a treatment required to be covered under Section 1367.353; and</ins>

<ins>(2) annually submit to the legislature a written report summarizing the data collected under Subdivision (1).</ins>

<ins>(b) The department may require a health benefit plan issuer to submit data to the department in the form and manner prescribed by the commissioner for purposes of complying with this subchapter.</ins>

### SECTION 2.

The changes in law made by this Act apply only to a health benefit plan that is delivered, issued for delivery, or renewed on or after January 1, 2028.

### SECTION 3.

This Act takes effect September 1, 2027.
````

### Current law this bill changes

Each section as it stands now, from this site's copy of the Texas Legislative Council's statute files (wording unchanged); the official page is the authority. Sections are matched automatically from the bill text and can be missed, for example when a bill changes a whole chapter at once.

- Insurance Code §1367.351 (added (new section))
  - New section: no current text.
- Insurance Code §1367.352 (added (new section))
  - New section: no current text.
- Insurance Code §1367.353 (added (new section))
  - New section: no current text.
- Insurance Code §1367.354 (added (new section))
  - New section: no current text.
- Insurance Code §1367.355 (added (new section))
  - New section: no current text.
- Insurance Code §1367.356 (added (new section))
  - New section: no current text.
- Insurance Code §1367.357 (added (new section))
  - New section: no current text.

### Authors and sponsors

Authors and coauthors serve in the originating chamber; sponsors and cosponsors in the other chamber. Authorship does not indicate a vote or caucus position.

#### Authors

- José Menéndez (Democratic · SD 26 · 26 years served · since 2001) · [bills](https://agent.billatlas.org/authors/senate-men-ndez.md)

_No coauthors, sponsors or cosponsors listed: no bill in this snapshot lists any yet, so this reflects the stage of the source data, not this bill._

### Recorded actions

1. 2026-11-10: Received by the Secretary of the Senate
2. 2026-11-10: Filed

## Computed by this site

Worked out by fixed rules from the official record above; not a statement by the Legislature.

- Status: Filed
- Most recent action type: Filed
- Hearing status: No hearing yet. No committee referral or hearing has been verified. A likelihood estimate would be premature.
- Authorship: Democratic author. Authors: 1 Democratic
- Author prominence: Senior author. 12 years in the Senate · 14 years in the House

## AI analysis (Luna)

Written by Luna, an AI model that reads the full bill text. It can be wrong; the bill text above is the authority. Tags marked caption-rules come from keyword rules applied to the caption, not from the AI.

### Summary

Reviewed 2026-11-14T03:43:35Z · introduced text. Fields from the full text: topics, agencies, impacts, constituencies, locations; other fields use caption inference.

The bill would require covered health benefit plans to cover medically necessary treatment for a child’s diagnosed pediatric neuroinflammatory disorder when the specified diagnostic and documentation conditions are met. It would also limit certain denials, cost-sharing and repeat preauthorization, and require the department to collect denial and appeal data and report annually; the changes would apply to plans delivered, issued or renewed on or after January 1, 2028.

### Topics

- Healthcare
- Business regulation

### Potentially affected agencies

Possible links are rule or model inferences, not confirmed legal obligations.

- **Texas Department of Insurance** (direct, luna-full-text): The department must collect denial and appeal data, report it annually to the legislature, and may require health benefit plan issuers to submit data.
- **Employees Retirement System of Texas** (inferred, luna-full-text): The bill applies its coverage requirements to a plan under Chapter 1551, which is administered by the Employees Retirement System of Texas.
- **Teacher Retirement System of Texas** (inferred, luna-full-text): The bill applies its coverage requirements to plans under Chapters 1575 and 1579, which are administered by the Teacher Retirement System of Texas.

### Types of impact

- Coverage for qualifying treatment
- Limits on treatment denials and cost-sharing
- Repeat preauthorization
- Denial and appeal reporting

### People and institutions affected

- Children younger than 18 with pediatric neuroinflammatory disorders
- Enrollees in covered health benefit plans and their treating physicians
- Health benefit plan issuers

### Locations

- Statewide (statewide): The bill amends Texas Insurance Code requirements for covered health benefit plans, with no narrower geographic limitation stated.

## Links

- Full bill text (official wording, Markdown): https://billatlas.org/live/text/SB336/I.md
- Official bill history: https://capitol.texas.gov/BillLookup/History.aspx?LegSess=90R&Bill=SB336
- Official bill text (every version, HTML/PDF/Word): https://capitol.texas.gov/BillLookup/Text.aspx?LegSess=90R&Bill=SB336
- Open in the tracker: https://billatlas.org/bill/SB336
- RSS feed of actions: https://billatlas.org/live/feeds/SB336.xml
- This page as JSON: https://agent.billatlas.org/bills/SB336.json
- Search all bills: https://agent.billatlas.org/search?q= followed by your words, e.g. https://agent.billatlas.org/search?q=Healthcare

---
Unofficial, independent open-source project; not a state website. The official record and bill text on this page are copied unchanged from the Texas Legislative Council bill files, refreshed hourly, so they can trail the Legislature by up to an hour or two. Computed fields and the AI analysis can be wrong. Not legal advice. For anything that matters, confirm on Texas Legislature Online.
